Literature DB >> 2162692

Quality of life during chemotherapy for small cell lung cancer: assessment and use of a daily diary card in a randomized trial.

D M Geddes1, L Dones, E Hill, K Law, P G Harper, S G Spiro, J S Tobias, R L Souhami.   

Abstract

Fifty-three patients who were taking part in a randomized trial of chemotherapy in small cell lung cancer (SCLC) were entered into a study of quality of life measurement using a daily diary card. Patients received either four or eight cycles of initial chemotherapy and daily records were scored, using a four point scale of nausea, sickness, appetite, sleep, mood, pain, activity and general well being. Two hundred and fifty-six of a possible 379 cards were returned (68% compliance). The first 31 patients took part in an assessment of the diary card where comparison was made with nurse ratings using the card, the EORTC questionnaire and the Spitzer quality of life index. These comparisons showed appropriate convergent and divergent validity and demonstrated the sensitivity of the diary card to short term changes compared with the other measures. In the randomized trial the diary card demonstrated a worsening of sickness and related variables as treatment continued. This spilled over into mood and general well being although physical variables of pain, sleep and activity were largely unaffected. Prophylactic cranial irradiation was associated with a transient increase in sickness and vomiting. The study shows that the diary card is an instrument sensitive to short term changes in quality of life and thus especially useful for comparing effects during the period of treatment.

Entities:  

Mesh:

Year:  1990        PMID: 2162692     DOI: 10.1016/0277-5379(90)90022-l

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  22 in total

Review 1.  Management of lung cancer.

Authors:  A Melville; A Eastwood
Journal:  Qual Health Care       Date:  1998-09

2.  Quality-of-life assessment in small cell lung cancer.

Authors:  P Fayers
Journal:  Pharmacoeconomics       Date:  1992-09       Impact factor: 4.981

Review 3.  Quality of life measurement for patients undergoing treatment for lung cancer.

Authors:  R J Fergusson; A Cull
Journal:  Thorax       Date:  1991-09       Impact factor: 9.139

4.  Approaches to the analysis of quality of life data: experiences gained from a medical research council lung cancer working party palliative chemotherapy trial.

Authors:  P Hopwood; R J Stephens; D Machin
Journal:  Qual Life Res       Date:  1994-10       Impact factor: 4.147

Review 5.  Evaluation of quality of life for diverse patient populations.

Authors:  K R Yabroff; B P Linas; K Schulman
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

6.  Cancer clinical outcomes for minority ethnic groups.

Authors:  P Selby
Journal:  Br J Cancer Suppl       Date:  1996-09

Review 7.  Quality of life as an outcome in breast cancer. Clinical application.

Authors:  J Bonneterre; S Schraub; S Lecomte; M Mercier
Journal:  Pharmacoeconomics       Date:  1996       Impact factor: 4.981

Review 8.  Critical review of the international assessments of health-related quality of life.

Authors:  R T Anderson; N K Aaronson; D Wilkin
Journal:  Qual Life Res       Date:  1993-12       Impact factor: 4.147

Review 9.  MRC quality of life studies using a daily diary card--practical lessons learned from cancer trials.

Authors:  P Fayers
Journal:  Qual Life Res       Date:  1995-08       Impact factor: 4.147

10.  The health-related quality of life and survival of small-cell lung cancer patients: results of a companion study to CALGB 9033.

Authors:  M J Naughton; J E Herndon; S A Shumaker; A A Miller; A B Kornblith; D Chao; J Holland
Journal:  Qual Life Res       Date:  2002-05       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.